Israel - English - Ministry of Health

tradis gat ltd - fluorescein sodium - solution for injection - fluorescein sodium 10 g / 100 ml - fluorescein - fluorescein - for examination of the retina by fluorescent angiography.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - fluorescein angiography of the fundus and of the iris vasculature. this medicinal product is for diagnostic use only.

Israel - English - Ministry of Health

tradis gat ltd - fluorescein sodium - solution for injection - fluorescein sodium 10 g / 100 ml - fluorescein - for examination of the retina by fluorescent angiography.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - fluorescein 100 mg/ml (as fluorescein sodium formed in process from fluorescein and sodium hydroxide);   - solution for injection - 500 mg/5ml - active: fluorescein 100 mg/ml (as fluorescein sodium formed in process from fluorescein and sodium hydroxide)   excipient: sodium hydroxide water for injection - fluorescein is indicated for angiography of the fundus and of the iris vasculature. this medicinal product is for diagnostic use only.

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmargus limited - fluorescein sodium - solution for injection - 100 milligram(s)/millilitre - fluorescein

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

serb sa-nv - fluorescein sodium 100 mg/ml - solution for injection - fluorescein sodium 100 mg/ml - fluorescein

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop sa-nv - fluorescein sodium 1 g/5 ml - solution for injection - 200 mg/ml - fluorescein sodium 200 mg/ml - fluorescein

United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno

United States - English - NLM (National Library of Medicine)

bausch & lomb americas inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product. risk summary there are no available data on the use of fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. fluorescein sodium and benoxinate hydrochloride ophthalmic solution, 0.3%/0.4% should be given to a pregnant woman only if clearly needed. risk summary there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of fluorescein sodium and beno